View in EDS

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.

Saved in:
Bibliographic Details
Title: Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Authors: Turkova A; Medical Research Council Clinical Trials Unit, University College London, London, UK. Electronic address: a.turkova@ucl.ac.uk., Waalewijn H; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Chan MK; Medical Research Council Clinical Trials Unit, University College London, London, UK., Bollen PDJ; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Bwakura-Dangarembizi MF; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Kekitiinwa AR; Baylor College of Medicine, Kampala, Uganda., Cotton MF; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa., Lugemwa A; Joint Clinical Research Centre, Mbarara, Uganda., Variava E; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Ahimbisibwe GM; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Srirompotong U; Pediatric Department, Khon Kaen Hospital, Khon Kaen, Thailand., Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Amuge P; Baylor College of Medicine, Kampala, Uganda., Zuidewind P; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa., Ali S; Medical Research Council Clinical Trials Unit, University College London, London, UK., Kityo CM; Joint Clinical Research Centre, Kampala, Uganda., Archary M; Department of Paediatrics and Child Health, King Edward VIII Hospital, Enhancing Care Foundation, University of KwaZulu-Natal, Durban, South Africa., Ferrand RA; London School of Hygiene & Tropical Medicine, London, UK., Violari A; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Gibb DM; Medical Research Council Clinical Trials Unit, University College London, London, UK., Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Ford D; Medical Research Council Clinical Trials Unit, University College London, London, UK., Colbers A; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
Corporate Authors: ODYSSEY Trial Team
Source: The lancet. HIV [Lancet HIV] 2022 Sep; Vol. 9 (9), pp. e627-e637. Date of Electronic Publication: 2022 Jul 19.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35868341
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Turkova+A%22">Turkova A</searchLink>; Medical Research Council Clinical Trials Unit, University College London, London, UK. Electronic address: a.turkova@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Waalewijn+H%22">Waalewijn H</searchLink>; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Chan+MK%22">Chan MK</searchLink>; Medical Research Council Clinical Trials Unit, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bollen+PDJ%22">Bollen PDJ</searchLink>; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bwakura-Dangarembizi+MF%22">Bwakura-Dangarembizi MF</searchLink>; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Kekitiinwa+AR%22">Kekitiinwa AR</searchLink>; Baylor College of Medicine, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Cotton+MF%22">Cotton MF</searchLink>; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Lugemwa+A%22">Lugemwa A</searchLink>; Joint Clinical Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Variava+E%22">Variava E</searchLink>; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Ahimbisibwe+GM%22">Ahimbisibwe GM</searchLink>; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Srirompotong+U%22">Srirompotong U</searchLink>; Pediatric Department, Khon Kaen Hospital, Khon Kaen, Thailand.<br /><searchLink fieldCode="AU" term="%22Mumbiro+V%22">Mumbiro V</searchLink>; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Amuge+P%22">Amuge P</searchLink>; Baylor College of Medicine, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Zuidewind+P%22">Zuidewind P</searchLink>; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Ali+S%22">Ali S</searchLink>; Medical Research Council Clinical Trials Unit, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Kityo+CM%22">Kityo CM</searchLink>; Joint Clinical Research Centre, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Archary+M%22">Archary M</searchLink>; Department of Paediatrics and Child Health, King Edward VIII Hospital, Enhancing Care Foundation, University of KwaZulu-Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Ferrand+RA%22">Ferrand RA</searchLink>; London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Violari+A%22">Violari A</searchLink>; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Gibb+DM%22">Gibb DM</searchLink>; Medical Research Council Clinical Trials Unit, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Burger+DM%22">Burger DM</searchLink>; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Ford+D%22">Ford D</searchLink>; Medical Research Council Clinical Trials Unit, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Colbers+A%22">Colbers A</searchLink>; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ODYSSEY+Trial+Team%22">ODYSSEY Trial Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101645355%22">The lancet. HIV</searchLink> [Lancet HIV] 2022 Sep; Vol. 9 (9), pp. e627-e637. <i>Date of Electronic Publication: </i>2022 Jul 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101645355 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3018 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523018%22">23523018 </searchLink><i>NLM ISO Abbreviation: </i>Lancet HIV <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35868341
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2352-3018(22)00160-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e627
    Titles:
      – TitleFull: Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Turkova A
      – PersonEntity:
          Name:
            NameFull: Waalewijn H
      – PersonEntity:
          Name:
            NameFull: Chan MK
      – PersonEntity:
          Name:
            NameFull: Bollen PDJ
      – PersonEntity:
          Name:
            NameFull: Bwakura-Dangarembizi MF
      – PersonEntity:
          Name:
            NameFull: Kekitiinwa AR
      – PersonEntity:
          Name:
            NameFull: Cotton MF
      – PersonEntity:
          Name:
            NameFull: Lugemwa A
      – PersonEntity:
          Name:
            NameFull: Variava E
      – PersonEntity:
          Name:
            NameFull: Ahimbisibwe GM
      – PersonEntity:
          Name:
            NameFull: Srirompotong U
      – PersonEntity:
          Name:
            NameFull: Mumbiro V
      – PersonEntity:
          Name:
            NameFull: Amuge P
      – PersonEntity:
          Name:
            NameFull: Zuidewind P
      – PersonEntity:
          Name:
            NameFull: Ali S
      – PersonEntity:
          Name:
            NameFull: Kityo CM
      – PersonEntity:
          Name:
            NameFull: Archary M
      – PersonEntity:
          Name:
            NameFull: Ferrand RA
      – PersonEntity:
          Name:
            NameFull: Violari A
      – PersonEntity:
          Name:
            NameFull: Gibb DM
      – PersonEntity:
          Name:
            NameFull: Burger DM
      – PersonEntity:
          Name:
            NameFull: Ford D
      – PersonEntity:
          Name:
            NameFull: Colbers A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2022 Sep
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3018
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The lancet. HIV
              Type: main
ResultId 1